Jennifer Belsky, DO, MSc

Dr. Jennifer Belsky is a pediatric oncologist and physician-scientist dedicated to improving supportive care and quality of life for children and adolescent young adults (AYAs) undergoing chemotherapy.

Her clinical and academic focus is on neurotoxicities, particularly chemotherapy-induced peripheral neuropathy (CIPN), which can cause long-term physical and emotional burdens for pediatric patients. With a background in both clinical oncology and translational research, Dr. Belsky integrates patient care with scientific inquiry to address unmet needs in pediatric cancer treatment. Her research centers on developing early, objective methods to detect and monitor CIPN, with a specific interest in neurofilament light chain (NfL) as a promising blood-based biomarker. She has led prospective studies evaluating NfL in children and AYAs with leukemia and lymphoma, demonstrating its potential to guide real-time clinical decisions and prevent long-term morbidity. Dr. Belsky’s work aims

to support timely interventions, reduce chemotherapy dose modifications, and ultimately improve outcomes for young patients receiving life-saving therapy.